Report overview
Anti-peptic Ulcre drug is one of various classes of drugs with different action mechanisms used to treat or ameliorate peptic ulcer or irritation of the gastrointestinal tract.
This report aims to provide a comprehensive presentation of the global market for Anti-Peptic Ulcer Drugs, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Anti-Peptic Ulcer Drugs. This report contains market size and forecasts of Anti-Peptic Ulcer Drugs in global, including the following market information:
Global Anti-Peptic Ulcer Drugs Market Revenue, 2018-2023, 2024-2029, ($ millions)
Global top five companies in 2022 (%)
The global Anti-Peptic Ulcer Drugs market was valued at US$ 8965.2 million in 2022 and is projected to reach US$ 20860 million by 2029, at a CAGR of 12.8% during the forecast period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
Global Anti-Peptic Ulcer Drugs key players include AstraZeneca, Ask-pharm, Takeda, Yangtze River Pharm, Shandong Luoxin, etc. Global top five players hold a share about 50%.
In terms of product, the segment includes Proton Pump Inhibitors (PPIs), Potassium-Competitive Acid Blockers (P-CAB), Antacids, H2 Antagonists, Ulcer Protective Drugs. And in terms of application, the application includes Gastritis, Gastric Ulcers, Duodenal Ulcers, Gastroesophageal Reflux Disease (GERD).
We surveyed the Anti-Peptic Ulcer Drugs companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Anti-Peptic Ulcer Drugs Market, by Type, 2018-2023, 2024-2029 ($ millions)
Global Anti-Peptic Ulcer Drugs Market Segment Percentages, by Type, 2022 (%)
Proton Pump Inhibitors (PPIs)
Potassium-Competitive Acid Blockers (P-CAB)
Antacids
H2 Antagonists
Ulcer Protective Drugs
Global Anti-Peptic Ulcer Drugs Market, by Application, 2018-2023, 2024-2029 ($ millions)
Global Anti-Peptic Ulcer Drugs Market Segment Percentages, by Application, 2022 (%)
Gastritis
Gastric Ulcers
Duodenal Ulcers
Gastroesophageal Reflux Disease (GERD)
Global Anti-Peptic Ulcer Drugs Market, By Region and Country, 2018-2023, 2024-2029 ($ Millions)
Global Anti-Peptic Ulcer Drugs Market Segment Percentages, By Region and Country, 2022 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Anti-Peptic Ulcer Drugs revenues in global market, 2018-2023 (estimated), ($ millions)
Key companies Anti-Peptic Ulcer Drugs revenues share in global market, 2022 (%)
Further, the report presents profiles of competitors in the market, key players include:
AstraZeneca
Ask-pharm
Takeda
Yangtze River Pharm
Shandong Luoxin
Huadong Medicine
Changzhou Siyao
Beijing Yuekang
Guangdong Dahua
Xian Janssen
Outline of Major Chapters:
Chapter 1: Introduces the definition of Anti-Peptic Ulcer Drugs, market overview.
Chapter 2: Global Anti-Peptic Ulcer Drugs market size in revenue.
Chapter 3: Detailed analysis of Anti-Peptic Ulcer Drugs company competitive landscape, revenue and market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Anti-Peptic Ulcer Drugs in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: The main points and conclusions of the report.
